- Home
- BMRN vs DDS Comparison
BMRN vs DDS Comparison
Compare BMRN & DDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | DDS |
|---|---|---|
| Founded | 1996 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 9.2B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | BMRN | DDS |
|---|---|---|
| Price | $59.35 | $644.46 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 19 | 3 |
| Target Price | $89.74 | ★ $511.33 |
| AVG Volume (30 Days) | ★ 2.9M | 147.7K |
| Earning Date | 02-18-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 4.90% |
| EPS Growth | ★ 59.53 | N/A |
| EPS | 2.68 | ★ 36.93 |
| Revenue | $3,094,001,000.00 | ★ $6,625,563,000.00 |
| Revenue This Year | $13.35 | $1.30 |
| Revenue Next Year | $9.06 | $0.57 |
| P/E Ratio | $22.18 | ★ $17.25 |
| Revenue Growth | ★ 12.39 | N/A |
| 52 Week Low | $50.76 | $282.24 |
| 52 Week High | $73.51 | $741.98 |
Technical Indicators
Market Signals| Indicator | BMRN | DDS |
|---|---|---|
| Relative Strength Index (RSI) | 60.47 | 50.66 |
| Support Level | $58.44 | $602.36 |
| Resistance Level | $59.82 | $645.00 |
| Average True Range (ATR) | 1.99 | 24.09 |
| MACD | 0.28 | -4.18 |
| Stochastic Oscillator | 64.74 | 45.71 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About DDS Dillard's Inc.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.